Sharecare’s SPAC confirmed, BrainQ’s Breakthrough Device Designation and more digital health news briefs

Posted on

SPAC rumors pan out. Only a few weeks after rumors unfold of Sharecare’s upcoming merger with a particular function acquisition firm (SPAC), the patient-engagement and benefits-navigation platform made it official with an announcement on Friday.

Sharecare will probably be merging with Falcon Capital Acquisition and itemizing on NASDAQ. The deal is about to be funded by way of $345 million in money in belief from Falcon and supported by a $425 million personal funding in public fairness and a direct funding from Anthem, which will probably be partnering with the mixed entity.

This deal will go away the corporate with about $400 million in development capital, in accordance with the announcement, and a complete enterprise worth of $3.9 billion.

HIMSS20 Digital

Study on-demand, earn credit score, discover merchandise and options. Get Began >>

“We began Sharecare to leverage improvements in client expertise – particularly the smartphone – to create a frictionless expertise that engages folks throughout the dynamic continuum of their healthcare wants,” Jeff Arnold, who will proceed his position as founder, chairman and CEO of Sharecare, stated in a press release. “By integrating fragmented level options and bringing collectively stakeholders throughout the healthcare ecosystem into one related digital care platform, we consider that Sharecare is uniquely positioned to rework the way in which folks entry, suppliers ship, and employers and well being plans administer prime quality, value environment friendly healthcare.”


Breakthrough Designation for stroke restoration remedy gadget. BrainQ, an Israeli firm that makes use of AI to ship electromagnetic area remedy to stroke sufferers by way of a wearable gadget, introduced final week that its system has obtained Breakthrough System Designation from the FDA. The company’s determination was based mostly on a current randomized managed trial carried out amongst ischemic stroke sufferers, which the corporate stated will probably be introduced publicly subsequent month on the American Coronary heart Affiliation’s annual Worldwide Stroke Convention.

“Stroke is a debilitating situation with restricted restoration choices, creating an enormous unmet want within the US,” Yotam Drechsler, CEO and cofounder of BrainQ, stated in a press release. “COVID-19 has solely made issues worse by limiting sufferers’ entry to remedy services. FDA Breakthrough Designation is a crucial milestone in our mission to cut back incapacity for these sufferers and deal with them within the consolation of their properties.”


App will assist examine COVID-19 vaccinations in Germany. docdok.well being, a Swiss-Israeli startup providing a healthcare communications platform connecting professions and sufferers, introduced yesterday a partnership with German specialist umbrella group the Nationwide Affiliation of Specialists in Germany (SpiFa) and its German Institute for Specialist Well being Companies Analysis (DIFA) on an app-based challenge to doc the security and effectiveness of COVID-19 vaccination.

The companions will distribute a docdok-built examine app to the group’s 160,000 healthcare supplier members as they obtain their COVID-19 vaccination. The app will request related info concerning unintended effects and different areas of curiosity over 12 months, knowledge that can then be transferred to DIFA for examine.

“With the anticipated outcomes, we are able to hopefully dispel current reservations amongst the inhabitants and obtain wider acceptance of the vaccination,” Dr. Yves Nordmann, cofounder and chief medical officer of docdok.well being, stated in a press release. “After launching comparable initiatives in different international locations, we’re hopeful that by launching DIFA1 app along with our companions SpiFa and DIFA, we are going to make a useful contribution to the combat in opposition to the coronavirus.”


Watson, what are my well being advantages? IBM Watson Well being and Humana have teamed up to make use of the previous’s conversational AI expertise as a digital assistant to assist the payer’s Employer Group members higher perceive their advantages. Introduced final week, the association will see the cloud-based IBM Watson Assistant for Well being Advantages deployed to 1.3 million medical and 1.8 million dental members off the bat. Consequently, the digital assistant will be capable of immediately reply members’ questions whereas serving to release Humana’s staff and name middle personnel.

“Navigating our well being protection with out the proper assist can probably function a barrier to care,” Paul Roma, common supervisor at IBM Watson Well being, stated in a press release. “An AI-enabled conversational agent that’s educated to know well being plan advantages logic can play a task in serving to to simplify advanced or probably complicated plan info.”

Leave a Reply

Your email address will not be published. Required fields are marked *